Coagulation abnormalities and their relationship with bleeding manifestations in patients with dengue-A single center observational study

Abstract

Objective: To evaluate coagulation abnormalities and their relationship with bleeding manifestations among patients with dengue. Methods: This observational study was conducted on 292 adult dengue patients who were admitted to a tertiary care hospital of Western India from July 2021 to June 2022. Coagulation tests including prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (aPTT), fibrinogen, and D-dimer were performed. Patients were monitored for bleeding manifestations. Results: Coagulation abnormalities were reported in 42.8% of the patients. Overall, prolonged aPTT was the most common coagulation abnormality (40.8%), followed by low fibrinogen (38.7%), raised D-dimer (31.2%), raised INR (26.0%) and prolonged PT (19.2%). Bleeding manifestations were present in 19.9% patients. PT, INR, aPTT and D-dimer levels were significantly higher (P<0.01) and fibrinogen level was significantly lower (P<0.001) in patients with bleeding compared to patients without bleeding. Patients with bleeding had a significantly higher rate of all coagulation abnormalities than patients without bleeding (P<0.01). Conclusions: Patients with bleeding showed a significantly higher frequency of coagulation abnormalities compared to patients without bleeding. Patients with dengue should be assessed for coagulation abnormalities.

Keywords

Dengue / Coagulation abnormalities / Coagulation parameters / Prothrombin time / Activated partial thromboplastin time / Bleeding manifestations

References

[1] Wilder-Smith A, Ooi EE, Horstick O, Willis B. Dengue. Lancet 2019; 393(10169):350-363.

[2] Weaver SC, Vasilakis N. Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol 2009; 9(4):523-540.

[3] World Health Organization. Dengue and severe dengue. [Online]. Available from:https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. [Accessed on 15 May 2021].

[4] Rachman A, Rinaldi I. Coagulopathy in dengue infection and the role of interleukin-6. Acta Med Indones 2006; 38(2):105-108.

[5] Singhi S, Kissoon N, Bansal A. Dengue and dengue hemorrhagic fever: Management issues in an intensive care unit. J Pediatr 2007; 83(2):S22-S35.

[6] Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature 2013; 496(7446):504-507.

[7] Nimmannitya S. Dengue hemorrhagic fever: Disorders of hemostasis. Paper presented at Proceeding International Congress of Hemotology, Asia-Pacific Division 1999; October 24-28, 1999; Bangkok, Thailand.

[8] Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18(3):392-397.

[9] Pranesh S. A Study of activated partial thromboplastin time and prothrombin time as predictors for impaired coagulation among patients with dengue virus infection in Coimbatore Medical College & Hospital, Coimbatore. MSc. Thesis. Coimbatore: Coimbatore Medical College; 2020.

[10] Kulasinghe S, Ediriweera R, Kumara P. Association of abnormal coagulation tests with dengue virus infection and their significance as early predictors of fluid leakage and bleeding. Sri Lanka J Child Health 2016; 45(3):184-188.

[11] Vibha V, Gajera, Shilpi S, Reeta D. Study of haematological profile of dengue fever and its clinical implication. Annals of Appl Bio-Sci 2016; 3:242-246.

[12] Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26(5):975-984.

[13] Isarangkura P, Pongpanich B, Pintadit P, Phanichyakarn P, Valyasevi A. Hemostatic derangement in dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18(3):331-339.

[14] Funahara Y, Shirahata A, Setiabudy-Dharma R. DHF characterized by acute type DIC with increased vascular permeability. Southeast Asian J Trop Med Public Health 1987; 18(3):346-350.

[15] Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic fever: Serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis 2002; 35(3):277-285.

[16] Hassan J, Borhany M, Abid M, Zaidi U, Fatima N, Shamsi T. Coagulation abnormalities in dengue and dengue haemorrhagic fever patients. Transfus Med 2020; 30(1):46-50.

[17] Marchi R, Nagaswami C, Weisel JW. Fibrin formation and lysis studies in dengue virus infection. Blood Coagul Fibrinolysis 2009; 20(7):575-582.

[18] World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization ; 2009.

[19] Khalil MAL, Tan J, Khalil MAU, Awan S, Rangasami M. Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan. BMC Res Notes 2014; 7(1):473.

[20] Yashaswini LS, Priya. A study of hematological parameters and requirement of platelet transfusion in dengue fever. Int J Adv Med 2017; 4(6):1668-1671.

[21] Kavitha R, Clarin JD. A study of incidence and significance of coagulopathy among dengue patients admitted in a tertiary care hospital at Tirunelveli, Tamil Nadu, India. Natl Lab Med 2020; 9(2):4-6.

[22] Hamsa BT, Srinivasa SV, Prabhakar K, Raveesha A, Manoj AG. Significance of APTT as early predictor of bleeding in comparison to thrombocytopenia in dengue virus infection. Int J Res Med Sci 2019; 7(1):67-70.

[23] Liu JW, Lee IK, Wang L, Chen RF, Yang KD. The usefulness of clinical-practice-based laboratory data in facilitating the diagnosis of dengue illness. Biomed Res Int 2013; 2013:198797. doi: 10.1155/2013/198797.

[24] Barbosa ACN, Montalvão SAL, Barbosa KGN, Colella MP, Annichino-Bizzacchi JM, Ozelo MC, et al. Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit. Res Pract Thromb Haemost 2019; 3(4):749-757.

[25] Kannan A, Narayanan KS, Sasikumar S, Philipose J, Surendran SA. Coagulopathy in dengue fever patients. Int J Res Med Sci 2014; 2(3):1070-1072.

[26] Balakrishnan V, Simna L, Kailas L. The coagulation profile of children admitted with dengue fever and correlation with clinical severity. Int J Contemp Pediatr 2017; 4(6):2109-2113.

[27] Kumari M, Roy A, Chatterjee A, Sarkar S, Pal PP. Hematological and coagulation profile of dengue infection in age group 1 to 12 years children in a tertiary care hospital. Panacea J Med Sci 2021; 11(2):341-353.

[28] Khan S, Baki MA, Ahmed T, Mollah MAH. Clinical and laboratory profile of dengue fever in hospitalized children in a tertiary care hospital in Bangladesh. BIRDEM Med J 2020; 10(3):200-203.

[29] Mallhi TH, Khan AH, Sarriff A, Adnan AS, Khan YH. Determinants of mortality and prolonged hospital stay among dengue patients attending tertiary care hospital: A cross-sectional retrospective analysis. BMJ Open 2017; 7(7):e016805. doi: 10.1136/bmjopen-2017-016805.

[30] Bashir BA, Saeed OK, Mohammed BA, Ageep AK. Partial thromboplastin time and prothrombin time as predictors for impaired coagulation among patients with dengue virus infection in Red Sea State of Sudan. Int J Hematol Disorders 2015; 2(1):24-28.

[31] Budastra N, Arhana BNP, Mudita IB. Plasma prothrombin time and activated partial thromboplastin time as predictors of bleeding manifestations during dengue hemorrhagic fever. Paediatrica Indonesiana 2009; 49(2):69-74.

[32] Trung DT, Thao LT, Hien T. Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg 2010; 83(4):774-780.

[33] Setrkraising K, Bongsebandhu-Phubhakdi C, Voraphani N, Pancharoen C, Thisyakorn U, Thisyakorn C, et al. D-dimer as an indicator of dengue severity. Asian Biomed 2007; 1(1):53-57.

[34] Adane T, Getawa S. Coagulation abnormalities in dengue fever infection: A systematic review and meta-analysis. PLoS Negl Trop Dis 2021; 15(8):e0009666. doi: 10.1371/journal.pntd.0009666.

[35] Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborío SI, Mercado JC, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 2005; 73(6):1063-1070.

[36] Aggarwal A, Chandra J, Aneja S, Patwari A, Dutta A. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr 1998; 35(8):727-732.